NCT02882282 2025-10-23
Pembrolizumab in Treating Patients With High Risk Oral Intraepithelial Neoplasia
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
NRG Oncology
M.D. Anderson Cancer Center
Hoosier Cancer Research Network
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fox Chase Cancer Center
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
Mayo Clinic
Cirujanos la Serena